Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0LE0E
|
|||
Former ID |
DNC012390
|
|||
Drug Name |
8-Fluoro-3-hydroxy-1H-benzo[b]azepine-2,5-dione
|
|||
Synonyms |
1H-1-Benzazepine-2,5-dione, 8-fluoro-3-hydroxy-; SCHEMBL9007832; CHEMBL142890; 144066-26-2
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C10H6FNO3
|
|||
Canonical SMILES |
C1=CC2=C(C=C1F)NC(=O)C(=O)C=C2O
|
|||
InChI |
1S/C10H6FNO3/c11-5-1-2-6-7(3-5)12-10(15)9(14)4-8(6)13/h1-4,13H,(H,12,14,15)
|
|||
InChIKey |
ZAZQJJXYILGMQL-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites. J Med Chem. 1996 Nov 8;39(23):4643-53. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.